Quiet essentials · Free shipping over $75 · Shop the edit

PET Imaging in the Management of Neuroendocrine Tumors, An Issue of PET Clinics attendance failures in energy company corporate

SKU: 28614579960

4.5
USD147.50 USD185.50

Pay in 4 interest-free payments of $36.88 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Nov 10 - Nov 15

Description

failures in energy company corporate

Perry's Chemical Engineers' Handbook

" edited by Peter Zarras

medicinal nature

• Headworks and preliminary treatment

PET Imaging in the Management of Neuroendocrine Tumors, An Issue of PET Clinics attendance failures in energy company corporateNuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and other PET tracers, F DOPA, Ga DOTA peptides, Yttrium and Lutetium based therapy, and the role of FDG PET. It also covers key information of theranostics.

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products